Ipsen Announces 18 Posters to Be Presented at the 15th Annual ENETS Conference
PARIS–(BUSINESS WIRE)– Ipsen (Euronext:IPN; ADR:IPSEY) today announced that lanreotide (Somatuline®), cabozantinib (Cabometyx®), and telotristat ethyl (Xermelo®), alongside research on real-world NET treatment, nuclear medicine and...